Sample Life Cycle Management in Modern Laboratories (DGLIMS)

Every laboratory result is only as reliable as the control applied throughout the sample’s life cycle. From the moment a sample is collected to the point where results are reported, archived, or discarded, each step introduces risk if it is not traceable, controlled, and auditable.

This page explains how sample life cycle management actually works in real laboratories, where breakdowns typically occur, and why structured control becomes essential as laboratories scale across industries, instruments, and regulatory frameworks.

What “Sample Life Cycle” Really Means in a Laboratory

In practice, a laboratory sample does not follow a single linear path. It passes through multiple stages, often handled by different people, instruments, and departments.

A complete sample life cycle typically includes:
  • Sample collection or receipt
  • Identification and accessioning
  • Preparation, splitting, or aliquoting
  • Assignment to tests and methods
  • Analysis across one or more instruments
  • Review, approval, and reporting
  • Storage, retention, re-analysis, or disposal

At each stage, decisions are made that directly affect data integrity, regulatory defensibility, and client or patient trust.

How Sample Control Breaks Down in Manual Systems

In many laboratories, sample life cycle tracking is distributed across:
  • Paper registers
  • Excel sheets
  • Instrument software
  • Email communication
While this may appear manageable at low volume, control weakens as:
  • Sample throughput increases
  • Multiple analysts handle the same sample
  • Samples are split or reused
  • Workflows overlap across shifts or departments
Common problems include:
  • Duplicate or reused sample IDs
  • Lost linkage between parent samples and derived portions
  • Unclear status of where a sample is in its workflow
  • Difficulty determining who last handled or approved a sample

These issues often remain hidden until audits, disputes, or investigations occur.

Why Parent–Child Traceability Is Critical

Many laboratory workflows require samples to be:
  • Split into subsamples
  • Aliquoted for parallel testing
  • Retained for future analysis
Without enforced parent–child relationships:
  • Results cannot be confidently linked back to the original sample
  • Re-analysis decisions become questionable
  • Entire datasets may lose credibility

In regulated or high-stakes environments, this loss of lineage is treated as a system failure, not a documentation oversight.

Sample Status Visibility and Decision Confidence

Laboratory managers and QA teams must be able to answer simple but critical questions at any time:
  • Has this sample been tested?
  • Is it awaiting analysis or review?
  • Has it been reported, stored, or discarded?
  • Was it handled under valid conditions?

When sample status is tracked informally, decisions rely on assumptions rather than evidence.

This increases the risk of:
  • Premature reporting
  • Duplicate testing
  • Missed deadlines
  • Non-defensible results

The Role of DGLIMS in Sample Life Cycle Governance

Within laboratory operations, DGLIMS functions as a centralized control framework for sample movement and status, not merely a tracking tool.

As sample volume and complexity grow, spreadsheets and paper logs fail to:
  • Enforce unique sample identity
  • Maintain lineage across splits and re-use
  • Provide real-time visibility into sample state
  • Support audit-ready reconstruction of events

A structured LIMS approach ensures that every sample action is recorded, attributable, and traceable across its entire life cycle.

Regulatory and Quality Expectations Around Sample Control

Auditors and inspectors consistently focus on:
  • Whether sample identity is preserved end-to-end
  • Whether handling steps are documented and justified
  • Whether results can be traced back to the original specimen
  • Whether sample disposition decisions are defensible

Correct results without demonstrable sample control are often rejected, especially under ISO, GMP, or accreditation frameworks.

When Sample Life Cycle Management Become Non-Negotiable

Formal sample life cycle governance becomes essential when:

At this stage, informal tracking introduces unacceptable operational and compliance risk.

    Laboratories handle high or variable sample volumes

    Samples are reused, retained, or re-tested

    Multiple instruments or departments are involved

    Regulatory or legal scrutiny is present

     Business reputation depends on defensible data


Conclusion

Sample life cycle management is not an administrative task. It is the foundation of laboratory credibility. As laboratories grow in scale, scope, and regulatory exposure, manual systems become fragile. Structured control ensures that every result can be trusted, defended, and reproduced long after the sample itself has moved on.